{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:36:37Z","timestamp":1793068597484,"version":"4.5.0"},"reference-count":65,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T00:00:00Z","timestamp":1660435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CNCS-UEFISCDI","award":["PN-III-P1-1.1-TE-2019-1345"],"award-info":[{"award-number":["PN-III-P1-1.1-TE-2019-1345"]}]},{"name":"CNCS-UEFISCDI","award":["P1-0134"],"award-info":[{"award-number":["P1-0134"]}]},{"name":"Slovenian Research Agency ARRS","award":["PN-III-P1-1.1-TE-2019-1345"],"award-info":[{"award-number":["PN-III-P1-1.1-TE-2019-1345"]}]},{"name":"Slovenian Research Agency ARRS","award":["P1-0134"],"award-info":[{"award-number":["P1-0134"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Melanoma is a skin cancer characterized by rapid growth and spread for which current therapies produce both resistance and increased risk of infection. To develop new anti-melanoma biocompatible species, the series of complexes Cu(N-N)(bzac)(X)\u22c5nH2O (N-N: 1,10-phenanthroline\/2,2\u2032-bipyridine, Hbzac: 1-phenyl-1,3-butanedione, X: NO3\/ClO4, and n = 0, 1) was studied. Single-crystal X-ray diffraction revealed a mononuclear structure for all complexes. The ability of the complexes to scavenge or trap reactive oxygen species such as O2\u22c5\u2212 and HO\u22c5 was proved by EPR spectroscopy experiments. All complexes inhibited B16 murine melanoma cells in a dose-dependent and nanomolar range, but the complexes with 1,10-phenanthroline were more active. Moreover, comparative activity on B16 and healthy BJ cells revealed a therapeutic index of 1.27\u20132.24. Bioinformatic methods were used to calculate the drug-likeness, pharmacokinetic, pharmacogenomic, and pharmacodynamic profiles of the compounds. The results showed that all compounds exhibit drug-likeness features, as well as promising absorption, distribution, metabolism, and excretion (ADME) properties, and no toxicity. The pharmacodynamics results showed that the neutral species appear to be good candidates for antitumor molecular targets (Tyrosyl-DNA phosphodiesterase 1, DNA-(apurinic or apyrimidinic site) lyase or Kruppel-like factor 5). Furthermore, the pharmacogenomic results showed a good affinity of the copper(II) complexes for the human cytochrome. These results recommend complexes bearing 1,10-phenanthroline as good candidates for developing drugs to melanoma alternative treatment.<\/jats:p>","DOI":"10.3390\/pharmaceutics14081692","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T03:33:20Z","timestamp":1660534400000},"page":"1692","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Antiproliferative Copper(II) Complexes Bearing Mixed Chelating Ligands: Structural Characterization, ROS Scavenging, In Silico Studies, and Anti-Melanoma Activity"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4208-0972","authenticated-orcid":false,"given":"Rodica","family":"Olar","sequence":"first","affiliation":[{"name":"Faculty of Chemistry, Department of Inorganic Chemistry, University of Bucharest, 90-92 Panduri Str., 050663 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6033-3710","authenticated-orcid":false,"given":"Catalin","family":"Maxim","sequence":"additional","affiliation":[{"name":"Faculty of Chemistry, Department of Inorganic Chemistry, University of Bucharest, 90-92 Panduri Str., 050663 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4018-7610","authenticated-orcid":false,"given":"Mihaela","family":"Badea","sequence":"additional","affiliation":[{"name":"Faculty of Chemistry, Department of Inorganic Chemistry, University of Bucharest, 90-92 Panduri Str., 050663 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7309-6002","authenticated-orcid":false,"given":"Mihaela","family":"Bacalum","sequence":"additional","affiliation":[{"name":"Horia Hulubei National Institute for Physics and Nuclear Engineering, Department of Life and Environmental Physics, 30 Reactorului Str., 077125 Magurele-Ilfov, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Raileanu","sequence":"additional","affiliation":[{"name":"Horia Hulubei National Institute for Physics and Nuclear Engineering, Department of Life and Environmental Physics, 30 Reactorului Str., 077125 Magurele-Ilfov, Romania"},{"name":"Faculty of Physics, Department of Electricity, Solid State and Biophysics, University of Bucharest, 405A Atomi\u0219tilor Str., 077125 Magurele-Ilfov, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Speranta","family":"Avram","sequence":"additional","affiliation":[{"name":"Faculty of Biology, Department of Anatomy, Animal Physiology and Biophysics, University of Bucharest, 91-95, Splaiul Independen\u021bei, 050095 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1484-5165","authenticated-orcid":false,"given":"Nata\u0161a \u010celan","family":"Koro\u0161in","sequence":"additional","affiliation":[{"name":"Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ve\u010dna pot 113, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora","family":"Burlanescu","sequence":"additional","affiliation":[{"name":"Laboratory of Optical Processes in Nanostructure Materials, National Institute of Materials Physics, 405A Atomi\u0219tilor Str., 077125 Magurele-Ilfov, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8190-9512","authenticated-orcid":false,"given":"Arpad Mihai","family":"Rostas","sequence":"additional","affiliation":[{"name":"Laboratory of Atomic Structures and Defects in Advanced Materials, LASDAM, National Institute of Materials Physics, 405A Atomi\u0219tilor Str., 077125 Magurele-Ilfov, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"214506","DOI":"10.1016\/j.ccr.2022.214506","article-title":"Revisiting metallodrugs for the treatment of skin cancers","volume":"462","author":"Manzano","year":"2022","journal-title":"Coord. Chem. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1365-2133.2003.05303.x","article-title":"Oxidative stress in malignant melanoma and non-melanoma skin cancer","volume":"148","author":"Sander","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2217\/mmt-2017-0003","article-title":"The role for chemotherapy in the modernmanagement of melanoma","volume":"4","author":"Gupta","year":"2017","journal-title":"Melanoma Manag."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1039\/C5MT00149H","article-title":"Targeting copper in cancer therapy: \u2018Copper That Cancer\u2019","volume":"7","author":"Denoyer","year":"2015","journal-title":"Metallomics"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/0929867323666160824162546","article-title":"Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity","volume":"24","author":"Leon","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"12879","DOI":"10.1039\/D0SC04082G","article-title":"Metallodrugs are unique: Opportunities and challenges of discovery and development","volume":"11","author":"Anthony","year":"2020","journal-title":"Chem. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Badea, M., Uivarosi, V., and Olar, R. (2020). Improvement in the Pharmacological Profile of Copper Biological Active Complexes by Their Incorporation into Organic or Inorganic Matrix. Molecules, 25.","DOI":"10.3390\/molecules25245830"},{"key":"ref_8","unstructured":"Balsa, L.M., Baran, E.J., and Le\u00f3n, I.E. (2021). Copper complexes as antitumor agents: In vitro and in vivo evidences. Curr. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jinorgbio.2014.04.004","article-title":"The cytotoxicity of the anticancer drug elesclomol is due to oxidative stress indirectly mediated through its complex with Cu(II)","volume":"137","author":"Hasinoff","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jinorgbio.2016.07.005","article-title":"Design and characterization of highly in vitro antitumor active ternary copper(II) complexes containing 2\u2019-hydroxychalcone ligands","volume":"163","author":"Hutyra","year":"2016","journal-title":"J. Inorg. Biochem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cbi.2015.02.023","article-title":"Magnetic property, DFT calculation, and biological activity of bis [(\u03bc2-chloro) chloro (1,10-phenanthroline)copper (II)] complex","volume":"231","author":"Mroueh","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"119533","DOI":"10.1016\/j.ica.2020.119533","article-title":"Structure, DFT studies, Magnetism and Biological activity of Bis[(\u03bc-azido)-chloro-(1,10-phenanthroline)-copper(II)] complex","volume":"506","author":"Hammud","year":"2020","journal-title":"Inorg. Chim. Acta."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/nar\/gky105","article-title":"Di-copper metallodrugs promote NCI-60 chemotherapy via singlet oxygen and superoxide production with tandem TA\/TA and AT\/AT oligonucleotide discrimination","volume":"46","author":"Slator","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ahmad, M., Suhaimi, S.-N., Chu, T.-L., Abdul Aziz, N., Mohd Kornain, N.-K., Samiulla, D.S., Lo, K.-W., Ng, C.-H., and Khoo, A.S.-B. (2018). Ternary copper(II) complex: NCI60 screening, toxicity studies, and evaluation of efficacy in xenograft models of nasopharyngeal carcinoma. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0191295"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jinorgbio.2018.07.011","article-title":"Sulfonamide-containing copper(II) metallonucleases: Correlations with in vitro antimycobacterial and antiproliferative activities","volume":"187","author":"Nakahata","year":"2018","journal-title":"J. Inorg. Biochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s10534-021-00334-9","article-title":"Antiproliferative and antibacterial properties of biocompatible copper(II) complexes bearing chelating N,N-heterocycle ligands and potential mechanisms of action","volume":"34","author":"Olar","year":"2021","journal-title":"Biometals"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Rostas, A.M., Badea, M., Ru\u021b\u0103, L.L., Farca\u0219anu, I.C., Maxim, C., Chifiriuc, M.C., Popa, M., Luca, M., Celan Koro\u0161in, N., and Cer\u010d Koro\u0161ec, R. (2020). Copper(II) complexes with mixed heterocycle ligands as promising antibacterial and antitumor species. Molecules, 25.","DOI":"10.3390\/molecules25173777"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ruta, L.L., Farcasanu, I.C., Bacalum, M., Raileanu, M., Rostas, A.M., Daniliuc, C.G., Chifiriuc, M.C., Marutescu, L., Popa, M., and Badea, M. (2021). Biological activity of triazolopyrimidine copper(II) complexes modulated by an auxiliary N-N-chelating heterocycle ligands. Molecules, 26.","DOI":"10.3390\/molecules26226772"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1080\/00958972.2012.690038","article-title":"Synthesis, characterization, and antitumor activities of two copper(II) complexes with pyrazole derivatives","volume":"65","author":"Ruan","year":"2012","journal-title":"J. Coord. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejmech.2016.07.018","article-title":"In vitro and in vivo studies of the antineoplastic activity of copper (II) compounds against human leukemia THP-1 and murine melanoma B16-F10 cell lines","volume":"123","author":"Borges","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/zaac.201700115","article-title":"Cytotoxic and Antimicrobial Properties of Copper (II) Complexes of Pyridine and Benzimidazole Derivatives","volume":"643","author":"Lisowska","year":"2017","journal-title":"Z. Anorg. Allg. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"129963","DOI":"10.1016\/j.bbagen.2021.129963","article-title":"Antitumoral synergism between a copper(II) complex and cisplatin improves in vitro and in vivo anticancer activity against melanoma, lung and breast cancer cells","volume":"1865","author":"Mariani","year":"2021","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_23","first-page":"e3998","article-title":"Synthesis and structural and DNA binding studies of mono and dinuclear copper (II) complexes constructed with \u2013O and \u2013N donor ligands: Potential anti-skin cancer drugs","volume":"31","author":"Gurudevaru","year":"2017","journal-title":"Appl. Organometal. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00686232","article-title":"Cardiotoxicity and antitumor activity of a copper (II)-doxorubicin chelate","volume":"25","author":"Monti","year":"1990","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1080\/00958972.2018.1447668","article-title":"New mononuclear copper(II) complexes from \u03b2-diketone and \u03b2-keto ester N-donor heterocyclic ligands: Structure, bioactivity and molecular simulation studies","volume":"71","author":"Salehi","year":"2018","journal-title":"J. Coord. Chem."},{"key":"ref_26","first-page":"299","article-title":"(Benzoylacetonato-O,O\u2019)(2,2\u2019-bipyridine-N,N\u2019)(nitrato-O)copper(II)","volume":"C53","author":"Zhang","year":"1997","journal-title":"Acta Cryst."},{"key":"ref_27","first-page":"800","article-title":"Advanced Structure-activity Relationships Applied to Mentha spicata L. Subsp. spicata Essential Oil Compounds as AChE and NMDA Ligands, in Comparison with Donepezil, Galantamine and Memantine\u2014New Approach in Brain Disorders Pharmacology","volume":"16","author":"Avram","year":"2022","journal-title":"CNS Neurol. Disord."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"680","DOI":"10.31925\/farmacia.2018.4.18","article-title":"Computational approaches of new perspectives in the treatment of depression during pregnancy","volume":"66","author":"Udrea","year":"2018","journal-title":"Farmacia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00894-004-0226-5","article-title":"Quantitative structure-activity relationship by CoMFA for cyclic urea and nonpeptidecyclic cyanoguanidine derivatives on the wild type and mutants HIV-1 protease","volume":"11","author":"Avram","year":"2005","journal-title":"J. Mol. Model."},{"key":"ref_30","unstructured":"Sheldrick, G.M. (1998). SHELXL-97, Program for Crystal Structure Refinement, University of G\u00f6ttingen."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Bordei Telehoiu, A.T., Nu\u021b\u0103, D.C., C\u0103proiu, M.T., Dumitrascu, F., Zarafu, I., Ioni\u021b\u0103, P., B\u0103diceanu, C.D., Avram, S., Chifiriuc, M.C., and Bleotu, C. (2020). Design, Synthesis and In Vitro Characterization of Novel Antimicrobial Agents Based on 6-Chloro-9H-carbazol Derivatives and 1,3,4-Oxadiazole Scaffolds. Molecules, 25.","DOI":"10.3390\/molecules25020266"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings 1PII of Original Article: S0169-409X9600423-1","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J. Comb. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular Properties That Influence the Oral Bioavailability of Drug Candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of Drug Absorption Using Multivariate Statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_37","unstructured":"(2022, June 22). Available online: http:\/\/biosig.unimelb.edu.au\/pkcsm\/."},{"key":"ref_38","unstructured":"(2022, June 22). Available online: https:\/\/prediction.charite.de\/."},{"key":"ref_39","unstructured":"(2022, June 22). Available online: https:\/\/prediction.charite.de\/subpages\/target_result.php."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1039\/b517989k","article-title":"Metal complexes as second-sphere ligands","volume":"30","author":"Madalan","year":"2006","journal-title":"New J. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00775-012-0912-1","article-title":"Identification of [CuCl(acac)(tmed)], a copper(II) complex with mixed ligands, as a modulator of Cu, Zn superoxide dismutase (Sod1p) activity in yeast","volume":"17","author":"Dumitru","year":"2012","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Nakamoto, K. (2009). Infrared and Raman Spectra of Inorganic and Coordination Compounds, Part B, Applications in Coordination, Organometallic, and Bioinorganic Chemistry, John Wiley & Sons. [6th ed.].","DOI":"10.1002\/9780470405888"},{"key":"ref_43","unstructured":"Wilkinson, G., Gillard, R.D., and McCleverty, J.A. (1987). Oxyanions. Comprehensive Coordination Chemistry, Pergamon Press. [1st ed.]."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Addison, A.W., Rao, T.N., Reedijk, J., van Rijn, J., and Verschor, G.C. (1984). Synthesis, structure, and spectroscopic properties of copper(II) compounds containing nitrogen\u2013sulphur donor ligands; the crystal and molecular structure of aqua[1,7-bis(N-methylbenzimidazol-2\u2032-yl)-2,6-dithiaheptane]copper(II) perchlorate. J. Chem. Soc. Dalton Trans., 1349\u20131356.","DOI":"10.1039\/DT9840001349"},{"key":"ref_45","unstructured":"Lever, A.B.P. (1986). Inorganic Electronic Spectroscopy, Elsevier."},{"key":"ref_46","unstructured":"Anatole, A., and Bleaney, B. (2012). Electron Paramagnetic Resonance of Transition Ion, Oxford University Press."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1002\/aoc.6471","article-title":"Copper (II) species with 1-(o-tolyl) biguanide: Structural characterization, ROS scavenging, antibacterial activity, biocompatibility and in silico studies","volume":"36","author":"Maxim","year":"2022","journal-title":"Appl. Organomet. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1021\/ed083p1229","article-title":"The Determination of the Geometry of Cu(II) Complexes An EPR Spectroscopy Experiment","volume":"83","author":"Garriba","year":"2006","journal-title":"J. Chem Ed."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"24450","DOI":"10.1038\/s41598-021-03909-1","article-title":"A selective CuII complex with 4-fluorophenoxyacetic acid hydrazide and phenanthroline displays DNA-cleaving and pro-apoptotic properties in cancer cells","volume":"11","author":"Machado","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1039\/D1QI00233C","article-title":"Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: Implications of the structure of a classical complex on its activity as an anticancer drug","volume":"8","author":"Ruiz","year":"2021","journal-title":"Inorg. Chem. Front."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"106092","DOI":"10.1016\/j.ejps.2021.106092","article-title":"Antiproliferative activity of two copper (II) complexes on colorectal cancer cell models: Impact on ROS production, apoptosis induction and NF-\u03baB inhibition","volume":"169","author":"Ruiz","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.poly.2014.12.026","article-title":"Copper(II) complexes with \u03b2-diketones and N-donor heterocyclic ligands: Crystal structure, spectral properties, and cytotoxic activity","volume":"89","author":"Almeida","year":"2015","journal-title":"Polyhedron"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"115621","DOI":"10.1016\/j.poly.2021.115621","article-title":"Tridentate acylhydrazone copper(II) complexes with heterocyclic bases as coligands. Synthesis, spectroscopic studies, crystal structure and cytotoxicity assays","volume":"213","author":"Balsa","year":"2022","journal-title":"Polyhedron"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1002\/aoc.6481","article-title":"New mixed ligand copper(II) hydrazone-based complexes: Synthesis, characterization, crystal structure, DNA\/RNA\/BSA binding, in vitro anticancer, apoptotic activity, and cell cycle analysis","volume":"36","author":"Elsayed","year":"2022","journal-title":"Appl. Organomet. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-4939-0888-2_2","article-title":"Cell Cycle Regulation by Checkpoints","volume":"1170","author":"Barnum","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"ref_56","first-page":"607","article-title":"The same, only different\u2014DNA damage checkpoints and their reversal throughout the cell cycle","volume":"128","author":"Shaltiel","year":"2015","journal-title":"J. Cell Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"540463","DOI":"10.1155\/2014\/540463","article-title":"A Schiff Base-Derived Copper (II) Complex Is a Potent Inducer of Apoptosis in Colon Cancer Cells by Activating the Intrinsic Pathway","volume":"2014","author":"Hajrezaie","year":"2014","journal-title":"Sci. World J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1039\/D1DT02988F","article-title":"Terpyridine copper(II) complexes as potential anticancer agents by inhibiting cell proliferation, blocking the cell cycle and inducing apoptosis in BEL-7402 cells","volume":"51","author":"Gu","year":"2022","journal-title":"Dalton Trans."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"10758","DOI":"10.1039\/C7DT01955F","article-title":"A Perspective\u2014Can copper complexes be developed as a novel class of therapeutics?","volume":"46","author":"Wehbe","year":"2017","journal-title":"Dalton Trans."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jinorgbio.2018.12.010","article-title":"Copper complexes for biomedical applications: Structural insights, antioxidant activity and neuron compatibility","volume":"192","author":"Esmaeili","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/neuonc\/noaa138","article-title":"TRIM24 Promotes Stemness and Invasiveness of Glioblastoma Cells via Activating SOX2 Expression","volume":"22","author":"Zhang","year":"2020","journal-title":"Neuro-Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1038\/s41467-019-12384-2","article-title":"Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24","volume":"10","author":"Yu","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Klapper, L., Idel, C., Kuppler, P., Jagomast, T., von Bernuth, A., Bruchhage, K.L., Rades, D., Offermann, A., Kirfel, J., and Perner, S. (2022). TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC. J. Pers. Med., 12.","DOI":"10.3390\/jpm12060991"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/cas.14910","article-title":"The roles and regulation of the KLF5 transcription factor in cancers","volume":"112","author":"Luo","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jcmgh.2019.11.009","article-title":"Kr\u00fcppel-like Factor 5 Regulates Stemness, Lineage Specification, and Regeneration of Intestinal Epithelial Stem Cells","volume":"9","author":"Kim","year":"2020","journal-title":"Cell. Mol. Gastroenterol. Hepatol."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/8\/1692\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:08:36Z","timestamp":1760141316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/8\/1692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,14]]},"references-count":65,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["pharmaceutics14081692"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14081692","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,14]]}}}